Search Results - "Tao, Nianjun"
-
1
Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER + Breast Cancer Patient-derived Xenograft Models
Published in Clinical cancer research (15-08-2017)“…Estrogen receptor-positive (ER ) breast cancers are typically treated with endocrine agents, and dependence on the ER pathway is often retained even after…”
Get full text
Journal Article -
2
Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors
Published in Breast cancer research : BCR (18-12-2019)“…Addition of CDK4/6 inhibitors (CDK4/6i) to endocrine therapy significantly increased progression-free survival, leading to their approval and incorporation…”
Get full text
Journal Article -
3
Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer
Published in Molecular cancer therapeutics (01-10-2010)“…Insulin-like growth factor-1 receptor (IGF-1R) is a receptor tyrosine kinase (RTK) and critical activator of the phosphatidylinositol 3-kinase-AKT pathway…”
Get full text
Journal Article -
4
Sequestration of Adenoviral Vector by Kupffer Cells Leads to a Nonlinear Dose Response of Transduction in Liver
Published in Molecular therapy (01-01-2001)“…Systemic administration of a recombinant adenovirus encoding the human interferon-β gene (H5.110CMVhIFN-β) results in transduction of hepatocytes and…”
Get full text
Journal Article -
5
Interferon-β Gene Therapy Inhibits Tumor Formation and Causes Regression of Established Tumors in Immune-Deficient Mice
Published in Proceedings of the National Academy of Sciences - PNAS (24-11-1998)“…Despite the potential of type 1 interferons (IFNs) for the treatment of cancer, clinical experience with IFN protein therapy of solid tumors has been…”
Get full text
Journal Article -
6
Antibody-Mediated Blockade of Integrin αvβ6Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β-Regulated Mechanism
Published in Cancer research (Chicago, Ill.) (15-01-2008)“…Abstract The αvβ6 integrin is up-regulated on epithelial malignancies and has been implicated in various aspects of cancer progression. Immunohistochemical…”
Get full text
Journal Article -
7
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
Published in Journal of cachexia, sarcopenia and muscle (01-12-2015)“…Background Cancer‐related weight loss is associated with increased inflammation and decreased survival. The novel inflammatory mediator growth differentiation…”
Get full text
Journal Article -
8
Abstract 1441: Induction of cancer cachexia by inflammatory molecules in directed complementation tumor models
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Cancer cachexia is a complex multi-factorial syndrome characterized by anorexia, body weight loss that is primarily due to the loss of skeletal muscle…”
Get full text
Journal Article -
9
Abstract 1153: Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Background: One of the most lethal and debilitating effects of cancer is the development of cancer-related anorexia-cachexia syndrome (CACS). It…”
Get full text
Journal Article -
10
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism
Published in Cancer research (Chicago, Ill.) (15-01-2008)“…The alpha(v)beta(6) integrin is up-regulated on epithelial malignancies and has been implicated in various aspects of cancer progression. Immunohistochemical…”
Get full text
Journal Article -
11
Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Background: We have provided initial evidence1 on the clinical usefulness of the cancer cachexia stages (CCS) proposed by Fearon et al2. However it is…”
Get full text
Journal Article -
12
Abstract 3504: Plasma growth differentiating factor-15 (GDF-15) and other inflammatory markers are associated with weight loss and poor prognosis in cancer patients
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Background: Cachexia is associated with increased inflammatory markers and decreased survival in cancer. Also, elevated GDF-15 has been associated…”
Get full text
Journal Article -
13
-
14
Abstract 1631: Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Abstract The Type 1 insulin-like growth factor receptor (IGF-1R) is a well established mediator of tumor cell proliferation and survival. IGF-1R is required…”
Get full text
Journal Article -
15
Abstract 646: Identification of FURIN as a tumor maintenance gene in solid tumors by in vivo Retroviral Mutagenesis and Directed Complementation
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract To identify tumor maintenance genes and pathways, we applied a genome-wide, large-scale functional screening approach using retrovirus-mediated…”
Get full text
Journal Article -
16
Abstract A233: Generation of in vitro and in vivo tumor models driven by insulin-like growth factor receptor (IGF1R) and their use in the development of OSI-906, a selective IGF1R inhibitor
Published in Molecular cancer therapeutics (10-12-2009)“…Abstract The emergence of insulin-like growth factor-1 receptor IGF1R as an important cancer target is evidenced by the growing number of clinical trials…”
Get full text
Journal Article -
17
Genetic code in evolution: switching species-specific aminoacylation with a peptide transplant
Published in The EMBO journal (02-01-1998)“…The genetic code is established in aminoacylation reactions whereby amino acids are joined to tRNAs bearing the anticodons of the genetic code. Paradoxically,…”
Get full text
Journal Article -
18
Antibody-Mediated Blockade of Integrin alpha sub(v) beta sub(6) Inhibits Tumor Progression In vivo by a Transforming Growth Factor- beta -Regulated Mechanism
Published in Cancer research (Chicago, Ill.) (01-01-2008)“…The alpha sub(v) beta sub(6) integrin is up-regulated on epithelial malignancies and has been implicated in various aspects of cancer progression…”
Get full text
Journal Article -
19
Cloning and Expression of a Gene Encoding an Integrin-Like Protein in Candida albicans
Published in Proceedings of the National Academy of Sciences - PNAS (09-01-1996)“…The existence of integrin-like proteins in Candida albicans has been postulated because monoclonal antibodies to the leukocyte integrins α M and α X bind to…”
Get full text
Journal Article -
20
Species-specific microhelix aminoacylation by a eukaryotic pathogen tRNA synthetase dependent on a single base pair
Published in Biochemistry (Easton) (03-10-1995)“…We report here that tyrosyl-tRNA synthetase from the eukaryotic pathogen Pneumocystis carinii is a 370 amino acid polypeptide with characteristic elements of a…”
Get full text
Journal Article